Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px
Organisation › Details

Basilea Pharmaceutica Ltd. (SIX: BSLN)

Basilea Pharmaceutica Ltd. is an integrated biopharmaceutical company headquartered in Basel, Switzerland, listed on the SWX Swiss Exchange (SWX:BSLN). Basilea is currently focused on the research, development and commercialization of new antibacterial, antifungal and dermatology drugs in the hospital and specialty care setting. *

 

Period Start 2000-10-01 splitoff
  Group Basilea (Group)
  Predecessor Roche (Group)
Products Industry antibiotic
  Industry 2 dermatic
Persons Person Scott, Ronald (Ron) (Basilea 201212–201804 CEO before COO before CFO RETIRED 2/18 proposed for Board)
  Person 2 Blatter, Joachim (Basilea 201201– CFO before Swissmetal Industries)
     
Region Region Basel BS
  Country Switzerland
  Street 487 Grenzacherstr.
  City 4058 Basel BS
  Tel +41-61-606-1111
    Address record changed: 2018-07-24
     
Basic data Employees D: 101 to 500 (2017-12-31)
  Currency CHF
  Annual sales 101,521,000 (revenue, total, consolidated (2017) 2017-12-31)
  Profit -19,360,000 (2017-12-31)
  Cash 200,724,000 (2017-12-31)
     
    * Document for �About Section�: 
     
   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x112px

More documents for Basilea (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px




» top